Literature DB >> 31661768

Protective Effect of Resveratrol Improves Systemic Inflammation Responses in LPS-Injected Lambs.

Yanping Liang1,2, Jianwei Zhou3, Kaixi Ji4, Hu Liu5, Allan Degen6, Manjun Zhai7, Dan Jiao8, Junqiang Guo9, Zongsheng Zhao10, Guo Yang11.   

Abstract

Highly intensive livestock production often causes immune stress to animals, which makes them more susceptible to infections. The aim of this study was to examine whether resveratrol (Res) alleviates inflammation in lambs. In Experiment 1, 16 male lambs were injected with lipopolysaccharides (LPS) at an initial dose of 0.25, 1.25, and 2.5 μg/kg body weight (BW) for 9 days. Average daily gain and blood parameters were measured and clinical symptoms were recorded. In Experiment 2, 20 male lambs were injected intravenously with LPS (0 mg/kg) + Res (0 mg), LPS (2.5 μg /kg) + Res (0 mg, 82.5 mg, 165 mg, 330 mg), 4 h after LPS injection. Jugular blood was collected from each lamb to determine white blood cell (WBC) counts and the expression of inflammatory genes. In Experiment 1, all LPS-treated lambs showed clinical signs of sickness including rhinorrhea, lethargy, and shivering, and systemic inflammatory responses of increased inflammatory genes levels and cortisol concentration. The lambs had increased respiratory and heart rates and rectal temperature and decreased average daily gain and feed intake. In Experiment 2, resveratrol significantly reduced WBCs and the expression levels of several genes associated with inflammation response (TLR4, NF-κB, c-jun) and inhibited the signaling cascades of NF-κB and MAPKs by down-regulating the expression levels of inflammatory cytokines (IL-1β, IL-4, IL-6, TNF-α, IFN-γ) induced by LPS. Resveratrol attenuated the LPS-evoked inflammatory responses in lambs by suppressing expression levels of inflammatory cytokines, and blocking NF-κB and MAPK signaling pathways.

Entities:  

Keywords:  cytokines; inflammation responses; lamb; lipopolysaccharide (LPS); resveratrol

Year:  2019        PMID: 31661768     DOI: 10.3390/ani9110872

Source DB:  PubMed          Journal:  Animals (Basel)        ISSN: 2076-2615            Impact factor:   2.752


  5 in total

1.  Resveratrol reduces cardiac NLRP3-inflammasome activation and systemic inflammation to lessen doxorubicin-induced cardiotoxicity in juvenile mice.

Authors:  Zaid H Maayah; Abrar S Alam; Shingo Takahara; Shubham Soni; Mourad Ferdaoussi; Nobutoshi Matsumura; Beshay N Zordoky; David D Eisenstat; Jason R B Dyck
Journal:  FEBS Lett       Date:  2021-05-06       Impact factor: 3.864

2.  Resveratrol Improves Bnip3-Related Mitophagy and Attenuates High-Fat-Induced Endothelial Dysfunction.

Authors:  Chen Li; Ying Tan; Jiandi Wu; Qinghui Ma; Shuchang Bai; Zhangqing Xia; Xiaoliang Wan; Jianqiu Liang
Journal:  Front Cell Dev Biol       Date:  2020-08-14

Review 3.  The Strategy of Boosting the Immune System Under the COVID-19 Pandemic.

Authors:  Mahmoud Alagawany; Youssef A Attia; Mayada R Farag; Shaaban S Elnesr; Sameer A Nagadi; Manal E Shafi; Asmaa F Khafaga; Husein Ohran; Abdulaziz A Alaqil; Mohamed E Abd El-Hack
Journal:  Front Vet Sci       Date:  2021-01-08

4.  Effect of dietary resveratrol supplementation on growth performance, antioxidant capacity, intestinal immunity and gut microbiota in yellow-feathered broilers challenged with lipopolysaccharide.

Authors:  Zhentao He; Yaojie Li; Taidi Xiong; Xiaoyan Nie; Huihua Zhang; Cui Zhu
Journal:  Front Microbiol       Date:  2022-08-25       Impact factor: 6.064

5.  Narciclasine attenuates LPS-induced acute lung injury in neonatal rats through suppressing inflammation and oxidative stress.

Authors:  Qingning Duan; Yin Jia; Yan Qin; Yingji Jin; Haozhong Hu; Jiebin Chen
Journal:  Bioengineered       Date:  2020-12       Impact factor: 3.269

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.